I 13.5 (Pemazyre 13.5 mg)
Generic Name: pemigatinib
Pill with imprint I 13.5 is White, Round and has been identified as Pemazyre 13.5 mg. It is supplied by Incyte Corporation.
Pemazyre is used in the treatment of cholangiocarcinoma of biliary tract and belongs to the drug class multikinase inhibitors. Pemazyre 13.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for I 13.5
Pemazyre
- Generic Name
- pemigatinib
- Imprint
- I 13.5
- Strength
- 13.5 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Incyte Corporation
- National Drug Code (NDC)
- 50881-0028
Related Images for "I 13.5"
More about Pemazyre (pemigatinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.